Скрининг РМЖ: история и реалии

Скрининг РМЖ: история и реалии

Автор: Эрштейн М.А., Меских Е.В., Колесник А.Ю., Оксанчук Е.А.

Журнал: Вестник Российского научного центра рентгенорадиологии Минздрава России @vestnik-rncrr

Рубрика: Обзоры

Статья в выпуске: 2 т.19, 2019 года.

Бесплатный доступ

Настоящий обзор освещает исторические аспекты и современные подходы к скринингу РМЖ у женщин.

Рмж, скрининг, маммография, автоматизированное ультразвуковое сканирование молочных желез, рентгеновский томосинтез, плотная молочная железа

Короткий адрес: https://sciup.org/149132099

IDR: 149132099

Список литературы Скрининг РМЖ: история и реалии

  • Заболотская Н.В., Заболотский В.С. Новые технологии в ультразвуковой маммографии. М.: ООО «Фирма СТРОМ». 2010. С. 82-86.
  • Каприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологичнской помощи населению России в 2017 году. М.: ФГБУ «МНИОИ им. П.А. Герцена Минздрава России». 2018.
  • Комарова Л.Е. Скрининг рака молочной железы. Современная онкология. 2006. Т. 4. № 2. С. 83-86.
  • Корженкова Г. П., Курдюкова Л. Н., Иванкина О. В. Скрининг рака молочной железы. Вестник РОНЦ им. Блохина. 2004.
  • Корженкова Г.П. Массовое маммографическое обследование женского населения с целью выявления рака молочной железы. Лучевая диагностика и терапия. 2015. № 2. С. 101-107.
  • Рожкова Н.И., Боженко В.К. Современные технологии скрининга рака молочной железы. Вопросы онкологии. 2009. Т. 55. № 4. С. 495-500.
  • Трофимова Е.Ю. Комплексная ультразвуковая диагностика заболеваний молочной железы: автореферат дис.. доктора медицинских наук: 14.00.19 / Моск. науч.исслед. онкол. ин-т им. П. А. Герцена МЗ Рос. Федерации. Москва. 2000. 50 с.
  • Чиссов В.И., Солодкий В.А., Пак Д.Д. и др. Скрининг рака молочной железы: история и перспективы. Онкология. Журнал им. П.А. Герцена. 2013. Т. 2. № 2. С. 46-51.
  • Чиссов В.И., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2010 году (заболеваемость и смертность). М. 2012. 260 с.
  • Anderson B.O., Yip C.H., Smith R.A., et al. Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer, 2008. V. 113 (8 Suppl). P. 2221-2243.
  • DOI: 10.1002/cncr.23844
  • Arora N., King T.A., Jacks L.M., et al. Impact of breast density on the presenting features of malignancy. Ann Surg Onc. 2010. V. 17. Suppl. 3. P. 211-218. 10.1245/s10434-010- 1237-3.
  • DOI: 10.1245/s10434-010-1237-3
  • Bae S.M., Moon W.K., Chang J.M., et al. Breast cancer detected with screening US: reason a not detection at mammography. Chang J Matal. Radiology. 2014. V. 270. No. 2. P. 369-
  • Berg W.A., Blume J.D., Cormack J.B., et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008. V. 299. No. 18. P. 2151-2163.
  • DOI: 10.1001/jama.299.18.2151
  • Bernardi D., Caumo F., Macaskill P., et al. Effect of integrating 3D-mammography (digital breast tomosynthesis) with 2D-mammography on radiologists' true-positive and false-positive detection in a population breast screening trial. Eur J Cancer. 2014. V. 50. No. 7. P. 1232-1238.
  • DOI: 10.1016/j.ejca.2014.02.004
  • Boyd N.F., Guo H., Martin L.J., et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007. V. 356. No. 3. P. 227-236.
  • Boyle P., Levin B., eds; World Cancer Report 2008. Lyon, France: World Health Organization. International Agency for Research on Cancer; 2008.
  • International Agency for Research on Cancer. IARC handbooks of cancer prevention. Vol.15 Breast cancer screening. Lyon, France: IARC Press, 2015.
  • Brem R.F., Tabár L., Duffy S.W., et al. Assessing improvement in detection of breast cancer with three-dimensional automated breast US in women with dense breast tissue: the SomoInsight Study. Radiology. 2015. V. 274. No. 3. P. 663-673.
  • Cruwys C., Pushkin J.A. Breast density and impacts on health. Ecancermedicalscience. 2017. V. 11. ed70.
  • DOI: 10.3332/ecancer.2017.ed70
  • Danaei G., Vander Hoorn S., Lopez A.D., et al. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005. V. 366. No. 9499. P. 1784-1793.
  • Emons J., Wunderle M., Hartmann A., et al. Initial clinical results with a fusion prototype for mammography and three-dimensional ultrasound with a tandard mammography system and a standard ultrasound probe. Acta Radiol. 2018. V. 59. No. 12. P. 1406-1413.
  • DOI: 10.1177/0284185118762249
  • Fasching P.A., Heusinger K., Loehberg C.R., et al. Influence of mammographic density on the diagnostic accuracy of tumor size assessment and association with breast cancer tumor characteristics. Eur J Radiol. 2006. V. 60. No. 3. P. 398-404.
  • Geiger-Gritsch S., Daniaux M., Buchberger W., et al. Performance of 4 years of population-based mammography screening for breast cancer combined with ultrasound in Tyrol/Austria. Wien Klin Wochenschr. 2018. V. 130. No. 3-4. P. 92-99.
  • DOI: 10.1007/s00508-017-1293-9
  • Kabayashi T. Grey-scale echography for breast cancer. Radiology. 1977. V. 122. No. 1. P. 207-214.
  • Kelsey J.L., Gammon M.D. The epidemiology of breast cancer. CA Cancer J Clin. 1991. V. 41. No. 3. P. 146-165.
  • Lacey J.V., Kreimer A.R., Buys S.S., et al. Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort. BMC Cancer. 2009. V. 9. P. 84.
  • DOI: 10.1186/1471-2407-9-84
  • Lee J.M., Partridge S.C., Liao G.J., et al. Double reading of automated breast ultrasound with digital mammography or digital breast tomosynthesis for breast cancer screening. Clin Imaging. 2019. V. 55. P. 119-125.
  • DOI: 10.1016/j.clinimag.2019.01.019
  • McCormack V.A., dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a metaanalysis. Cancer Epidemiol Biomarkers Prev. 2006. V. 15. No.6.P. 1159-1169.
  • Oeffinger K.C., Fontham E.T., Etzioni R., et al. American Cancer Society. Breast cancernscreening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015. V. 314. No. 15. P. 1599-1614.
  • DOI: 10.1001/jama.2015.12783
  • Pamilo M., Soiva M., Anttinen I., et al. Ultrasonography of breast lesions detected in mammography screening. Acta Radiol. 1991. V. 32. No. 3. P. 220-225.
  • Pattacini P., Nitrosi A., Giorgi Rossi P., et al. Digital Mammography versus Digital Mammography Plus Tomosynthesis for Breast Cancer Screening: The Reggio Emilia Tomosynthesis Randomized Trial. Radiology. 2018. V. 288. No. 2. P. 375-385.
  • DOI: 10.1148/radiol.2018172119
  • Peto J. Cancer epidemiology in the last century and the next decade. Nature. 2001. V.411.No. 6835. P. 390-395.
  • Pisano E.D., Gatsonis C., Hendrick E., et al. Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening. N Engl J Med. 2005. V. 353. No. 17. P. 1-11.
  • Posso M., Louro J., Sánchez M., et al. Mammographic breast density: How it affects performance indicators in screening programmes? Eur J Radiol. 2019. V. 110. P. 81-87.
  • DOI: 10.1016/j.ejrad.2018.11.012
  • Román M., Sala M., Baré M., et al. Changes in mammographic density over time and the risk of breast cancer: An observational cohort study. Breast. 2019. V. 46. P. 108-115.
  • DOI: 10.1016/j.breast.2019.04.007
  • Scheel J.R., Lee J.M., Sprague B.L., et al. Screening ultrasound as an adjunct to mammography in women with mammographically dense breasts. Am J Obstet Gynecol. 2015. V. 212. No. 1. P. 9-17.
  • DOI: 10.1016/j.ajog.2014.06.048
  • Smith R.A., Duffy S.W., Gabe R., et al. The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am. 2004. V. 42. No. 5. P. 793-806.
  • Sprague B.L., Stout N.K., Schechter C. et al. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med. 2015. V. 162. No. 3. P. 157-166.
  • DOI: 10.7326/M14-0692
  • Tabár L., Vitak B., Chen T.H., et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011. V. 260. No. 3. P. 658-663.
  • DOI: 10.1148/radiol.11110469
  • Tabar L., Fagerberg G., Duffy S.W., Day N.E. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health. 1989. V. 43. No. 2. P. 107-114.
  • Takada E., Sunagawa M., Marikubo H. Breast cancer mass screening by ultrasonic examination. Ultrasound Med Biol Supp B. 2000. V. 26. No. 4. P. 10.
  • Vacek P.M., Geller B.M. A prospective study of breast cancer risk using routine mammographic breast density measurements. Cancer Epidemiol Biomarkers Prev. 2004. V. 13. No. 5. P. 715-722.
  • Vourtsis A, Kachulis A. The performance of 3D ABUS versus HHUS in the visualisation and BI-RADS characterization of breast lesions in a large cohort of 1,886 women. Eur Radiol. 2018. V. 28. No. 2. P. 592-601.
  • Wilczek B., Wilczek H.E., Rasouliyan L., Leifland K. Adding 3D automated breast ultrasound to mammography screening in women with heterogeneously and extremely dense breasts: Report from a hospital-based, high-volume, single-center breast cancer screening program. Eur J Radiol. 2016. V. 85. No. 9. P. 1554-1163.
  • DOI: 10.1016/j.ejrad.2016.06.004
  • Zha N., Alabousi M., Patel B.K., Patlas M.N. Beyond Universal Health Care: Barriers to Breast Cancer Screening Participation in Canada. J Am Coll Radiol. 2019. V. 16. (4 Pt B). P. 570-579.
Еще
Статья научная
SciUp 2024 © 2024 ©